Proliferation-coupled osteoclast differentiation by RANKL: Cell density as a determinant of osteoclast formation

Area of Science:

• Cell Biology
• Immunology
• Bone Biology

Background:

• Osteoclast differentiation is crucial for bone remodeling.
• Receptor activator of nuclear factor kappa-B ligand (RANKL) is a key cytokine in osteoclastogenesis.
• RANKL's role in osteoclast proliferation is complex and debated.

Purpose of the Study:

• To investigate the dual role of RANKL in osteoclast proliferation and differentiation.
• To elucidate the cell cycle dynamics during osteoclastogenesis.
• To determine the critical factors influencing osteoclast formation.

Main Methods:

• Ex vivo osteoclast differentiation model.
• Fucci cell cycle indicators for cell tracing.
• Hydroxyurea (HU) to inhibit DNA synthesis.
• Manipulation of cell numbers at different culture stages.

Main Results:

• RANKL stimulates DNA synthesis and proliferation in early osteoclastogenesis (0-48h) but inhibits it later (48-96h).
• Cell cycle arrest and fusion occur after 48h.
• Inhibition of DNA synthesis early on can be rescued by increasing cell density later.
• Initial and intermediate cell numbers significantly impact osteoclast formation and timing.

Conclusions:

• Osteoclast formation critically depends on achieving a sufficient cell number rather than solely on early DNA synthesis.
• RANKL exhibits a biphasic effect on osteoclast proliferation.
• Manipulating cell numbers before fusion can lead to misinterpretation of differentiation studies.